In a Florida title agency sale the license is the easy part. The underwriting agreement, the escrow reconciliations, and the people are what the buyer is actually pricing.
Florida treatment center deals close through DCF relicensure, not license transfer — and diligence runs straight into the Patient Brokering Act’s felony tiers.
Rollover equity often arrives with vesting attached. When an 83(b) election is needed, when it isn’t, and how the IRS’s online Form 15620 changes the filing.
Amendment 2’s last step lands September 30, 2026. Labor-cost step-ups, wage-and-hour diligence, and successor risk for anyone buying a Florida workforce.
Estate planning moves stock into trusts; not every trust can hold S corporation shares. How QSST and ESBT elections go missing, and how deals close anyway.
Produce inventory and its receivables may sit in a federal statutory trust for unpaid growers. What PACA and Florida’s ch. 604 dealer license mean for buyers.
Delaware’s Revlon doctrine doesn’t govern Florida corporations. What § 607.0830 asks of a board selling the company, and why careful process still wins.
Florida’s Health Care Clinic Act can end a med spa’s licensure exemption at closing. The ownership tests, the CHOW clock, and the criminal traps.
Florida’s Supreme Court says FDUTPA reaches even a single business sale. Why buyers still lose on damages, and why the fee-shift makes it a two-edged claim.
SOP 50 10 8 rewrote SBA 7(a) acquisition rules: a 10% equity floor, full-standby seller notes, and no earnouts. What that does to Florida main-street deals.